A detailed history of Northern Trust Corp transactions in 23and Me Holding Co. stock. As of the latest transaction made, Northern Trust Corp holds 2,359,802 shares of ME stock, worth $755,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,359,802
Previous 2,611,734 9.65%
Holding current value
$755,136
Previous $1.38 Million 33.53%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.36 - $0.61 $90,695 - $153,678
-251,932 Reduced 9.65%
2,359,802 $920,000
Q1 2024

May 14, 2024

SELL
$0.4 - $0.91 $30,459 - $69,295
-76,149 Reduced 2.83%
2,611,734 $1.38 Million
Q4 2023

Feb 13, 2024

BUY
$0.71 - $0.97 $229,811 - $313,967
323,678 Added 13.69%
2,687,883 $2.45 Million
Q3 2023

Nov 13, 2023

BUY
$0.96 - $2.01 $68,943 - $144,350
71,816 Added 3.13%
2,364,205 $2.32 Million
Q2 2023

Aug 11, 2023

SELL
$1.59 - $2.29 $191,130 - $275,276
-120,208 Reduced 4.98%
2,292,389 $4.01 Million
Q1 2023

May 15, 2023

SELL
$2.05 - $2.87 $1,230 - $1,722
-600 Reduced 0.02%
2,412,597 $5.5 Million
Q4 2022

Feb 13, 2023

BUY
$2.06 - $3.47 $226,682 - $381,838
110,040 Added 4.78%
2,413,197 $5.21 Million
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.12 $1.86 Million - $3.66 Million
715,514 Added 45.07%
2,303,157 $6.59 Million
Q2 2022

Aug 12, 2022

BUY
$2.19 - $3.98 $2.6 Million - $4.73 Million
1,188,202 Added 297.47%
1,587,643 $3.94 Million
Q1 2022

May 13, 2022

BUY
$3.28 - $7.12 $751,736 - $1.63 Million
229,188 Added 134.62%
399,441 $1.53 Million
Q4 2021

Feb 08, 2022

BUY
$6.55 - $13.25 $142,567 - $288,399
21,766 Added 14.66%
170,253 $1.13 Million
Q3 2021

Nov 15, 2021

BUY
$7.29 - $11.0 $1.08 Million - $1.63 Million
148,487 New
148,487 $1.35 Million

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $83.1M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.